StonvexLoading…
StonvexStonvexStonvexCore line items from PLRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $1.58M | $9.69M |
Operating Income | $-156.37M | $-228.37M | $-184.15M | $-127.20M |
Net Income | $-149.34M | $-210.30M | $-161.34M | $-123.32M |
EPS (Diluted) | $-2.43 | $-3.47 | $-2.75 | $-2.94 |
Total Assets | $225.23M | $396.95M | $512.15M | $350.61M |
Total Liabilities | $44.02M | $92.87M | $38.58M | $37.27M |
Cash & Equivalents | $45.45M | $71.19M | $63.23M | $33.69M |
Free Cash Flow OCF − CapEx | $-128.71M | $-159.35M | $-117.28M | $-96.39M |
Shares Outstanding | 61.45M | 60.86M | 59.92M | 48.94M |